Cotización Invesco FTSE RAFI Develo... - PXF

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

47.76

Postura de Compra

Postura de Venta

Volume Operado de la Acción

80,910

47.26 Rango del Día 48.0524

45.46 Rango de 52 semanas 52.89

Capitalización de Mercado [m]

1.688B

Precio Anterior

47.72

Precio de Apertura

47.32

Hora

100

47.76

Última hora de negociación

Volumen financiero

US$ 3,875,417

Precio Promedio Ponderado

47.8979

Volumen promedio (3 m)

73,302

Acciones en circulación

35,350,000

Rendimiento del Dividendo

Ratio Precio/Utilidad

9.58

Beneficio por acción (BPA)

4.98

turnover

58.31M

Beneficio neto

176.16M

The investment seeks to track the investment results (before fees and expenses) of the FTSE RAFITM Developed ex U. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index, as well as American depositary receipts (ADRs) and global depositar... The investment seeks to track the investment results (before fees and expenses) of the FTSE RAFITM Developed ex U. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index, as well as American depositary receipts (ADRs) and global depositary receipts (GDRs) that represent securities in the underlying index. The underlying index is comprised of companies originating in countries that are classified as developed within the country classification definition of FTSE, excluding the United States. Mostrar más

Sector

Mgmt Invt Offices, Open-end

Industria

Mgmt Invt Offices, Open-end

Sitio web

www.invesco.com

Sede

Boston, Massachusetts, USA

Fundado

Invesco FTSE RAFI Developed Markets exUS ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker PXF. The last closing price for Invesco FTSE RAFI Develo... was US$47.72. Over the last year, Invesco FTSE RAFI Develo... shares have traded in a share price range of US$ 45.46 to US$ 52.89.

Invesco FTSE RAFI Develo... currently has 35,350,000 shares in issue. The market capitalisation of Invesco FTSE RAFI Develo... is US$1.69 billion. Invesco FTSE RAFI Develo... has a price to earnings ratio (PE ratio) of 9.58.

No news to show yet.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-1.82	-3.67083501412	49.58	49.58	47.6299	259135	48.52675402	SP
4	-1.09	-2.23132036847	48.85	50.3884	47.6299	113093	48.92186041	SP
12	-4.86	-9.23603192702	52.62	52.89	47.6299	73302	49.4698894	SP
26	-1.43	-2.907094938	49.19	52.89	46.21	70629	49.53346316	SP
52	1.07	2.29171128721	46.69	52.89	45.46	69008	49.11148609	SP
156	2.07	4.53053184504	45.69	52.89	34.56	134331	42.90779566	SP
260	5.17	12.1389997652	42.59	52.89	26.1	159964	39.5311566	SP

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M